These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 6410531

  • 1. Blood viscosity and haemostasis in the nephrotic syndrome.
    McGinley E, Lowe GD, Boulton-Jones M, Forbes CD, Prentice CR.
    Thromb Haemost; 1983 Jun 28; 49(3):155-7. PubMed ID: 6410531
    [Abstract] [Full Text] [Related]

  • 2. Abnormal haemostasis and blood viscosity in malignant hypertension.
    Isles C, Lowe GD, Rankin BM, Forbes CD, Lucie N, Lever AF, Kennedy AC.
    Thromb Haemost; 1984 Dec 29; 52(3):253-5. PubMed ID: 6241751
    [Abstract] [Full Text] [Related]

  • 3. Plasma viscosity as a cardiovascular risk marker in patients with proteinuria.
    Ercan M, Konukoglu D, Onen S.
    Clin Hemorheol Microcirc; 2003 Dec 29; 29(2):111-6. PubMed ID: 14610306
    [Abstract] [Full Text] [Related]

  • 4. Plasma viscosity in nephrotic Nigerians.
    Oviasu E, Famodu AA, Ojeh EA.
    Clin Hemorheol Microcirc; 1998 Oct 29; 19(2):163-7. PubMed ID: 9849930
    [Abstract] [Full Text] [Related]

  • 5. High levels of tissue factor pathway inhibitor in patients with nephrotic proteinuria.
    Ariëns RA, Moia M, Rivolta E, Ponticelli C, Mannucci PM.
    Thromb Haemost; 1999 Sep 29; 82(3):1020-3. PubMed ID: 10494757
    [Abstract] [Full Text] [Related]

  • 6. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.
    Zwaginga JJ, Koomans HA, Sixma JJ, Rabelink TJ.
    J Clin Invest; 1994 Jan 29; 93(1):204-11. PubMed ID: 8282789
    [Abstract] [Full Text] [Related]

  • 7. Comprehensive study of haemostasis in nephrotic syndrome.
    Panicucci F, Sagripanti A, Vispi M, Pinori E, Lecchini L, Barsotti G, Giovannetti S.
    Nephron; 1983 Jan 29; 33(1):9-13. PubMed ID: 6403881
    [Abstract] [Full Text] [Related]

  • 8. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C.
    Clin Endocrinol (Oxf); 2006 Mar 29; 64(3):323-9. PubMed ID: 16487444
    [Abstract] [Full Text] [Related]

  • 9. Plasma fibronectin and factor XIII in nephrotic syndrome.
    Rus HG, Cucuianu M, Manasia M, Spînu C, Cristea A, Nanulescu M.
    Med Interne; 1987 Mar 29; 25(2):105-11. PubMed ID: 3112925
    [Abstract] [Full Text] [Related]

  • 10. Increased aggregation with normal surface charge and deformability of red blood cells in children with nephrotic syndrome.
    Böhler T, Linderkamp O, Leo A, Wingen AM, Schärer K.
    Clin Nephrol; 1992 Sep 29; 38(3):119-24. PubMed ID: 1395161
    [Abstract] [Full Text] [Related]

  • 11. [Changes in several blood coagulation parameters in the nephrotic syndrome].
    Gasparotto ML, Bertoli M, Bertaglia E, Vertolli U, Varchetta V, Favaro P, Rebeschini M, Di Lavoro D, Romagnoli GF.
    Minerva Nefrol; 1981 Sep 29; 28(1):15-9. PubMed ID: 6793942
    [No Abstract] [Full Text] [Related]

  • 12. [Mechanism of renal vein thrombosis in patients with nephrotic syndrome: a prospective study].
    Cheng H.
    Zhonghua Yi Xue Za Zhi; 1992 Jul 29; 72(7):416-9, 447. PubMed ID: 1330232
    [Abstract] [Full Text] [Related]

  • 13. [Evaluation of selected parameters of hemostasis in patients with nephrotic syndrome].
    Rowiński M, Rydzewski A, Małyszko JS, Małyszko J, Myśliwiec M.
    Przegl Lek; 1994 Jul 29; 51(2):77-81. PubMed ID: 8058973
    [Abstract] [Full Text] [Related]

  • 14. Elevation of blood viscosity, aggregation of red cells, haematocrit values and fibrinogen levels with cigarette smokers.
    Dintenfass L.
    Med J Aust; 1975 May 17; 1(20):617-20. PubMed ID: 1143159
    [Abstract] [Full Text] [Related]

  • 15. Behaviour of fibrinolysis in the nephrotic syndrome.
    Cucuianu M, Manasia M, Spînu C, Mărcuşu C, Roman S, Comănescu A.
    Med Interne; 1988 May 17; 26(2):109-14. PubMed ID: 3133746
    [Abstract] [Full Text] [Related]

  • 16. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome.
    Vaziri ND, Gonzales EC, Shayestehfar B, Barton CH.
    J Lab Clin Med; 1994 Jul 17; 124(1):118-24. PubMed ID: 7518491
    [Abstract] [Full Text] [Related]

  • 17. Platelet aggregation and beta-thromboglobulin levels in nephrotic patients with and without thrombosis.
    Kuhlmann U, Steurer J, Rhyner K, von Felten A, Briner J, Siegenthaler W.
    Clin Nephrol; 1981 May 17; 15(5):229-35. PubMed ID: 6166421
    [Abstract] [Full Text] [Related]

  • 18. Factor XII and other hemostatic protein abnormalities in nephrotic syndrome patients.
    Thompson AR.
    Thromb Haemost; 1982 Aug 24; 48(1):27-32. PubMed ID: 6813992
    [Abstract] [Full Text] [Related]

  • 19. Activation of platelets in patients with chronic proliferative glomerulonephritis and the nephrotic syndrome.
    Tomura S, Ida T, Kuriyama R, Chida Y, Takeuchi J, Motomiya T, Yamazaki H.
    Clin Nephrol; 1982 Jan 24; 17(1):24-30. PubMed ID: 6459902
    [Abstract] [Full Text] [Related]

  • 20. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
    Erem C, Kocak M, Hacihasanoglu A, Yilmaz M, Saglam F, Ersoz HO.
    Exp Clin Endocrinol Diabetes; 2008 Nov 24; 116(10):619-24. PubMed ID: 18484067
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.